Items where authors include "Gollins, S"

Article

Hudson, EM orcid.org/0000-0001-8758-7163, Noutch, S, Brown, S orcid.org/0000-0002-7975-7537 et al. (19 more authors) (2022) A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. BMJ Open, 12 (4). e049119. ISSN 2044-6055

Mukherjee, S, Hurt, C, Radhakrishna, G et al. (17 more authors) (2021) Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial. European Journal of Cancer, 153. pp. 153-161. ISSN 0959-8049

Hanna, CR, Slevin, F orcid.org/0000-0002-7176-904X, Appelt, A orcid.org/0000-0003-2792-9218 et al. (17 more authors) (2021) Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020. Clinical Oncology, 33 (4). pp. 214-223. ISSN 0936-6555

Chadi, SA, Malcomson, L, Ensor, J et al. (30 more authors) (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet Gastroenterology and Hepatology, 3 (12). pp. 825-836. ISSN 2468-1253

Clifford, R, Govindarajah, N, Parsons, JL et al. (3 more authors) (2018) Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. British Journal of Surgery, 105 (12). pp. 1553-1572. ISSN 0007-1323

Gollins, S, West, N orcid.org/0000-0002-0346-6709, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (11 more authors) (2018) A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer, 119 (6). pp. 697-706. ISSN 0007-0920

van der Valk, MJM, Hilling, DE, Bastiaannet, E et al. (66 more authors) (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. The Lancet, 391 (10139). pp. 2537-2545. ISSN 0140-6736

Alderdice, M, Richman, SD orcid.org/0000-0003-3993-5041, Gollins, S et al. (12 more authors) (2018) Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies. Journal of Pathology, 245 (1). pp. 19-28. ISSN 0022-3417

Gollins, S, West, N orcid.org/0000-0002-0346-6709, Sebag-Montefiore, D et al. (17 more authors) (2017) Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. British Journal of Cancer, 117. pp. 1286-1294. ISSN 0007-0920

Mukherjee, S, Hurt, CN, Gwynne, S et al. (15 more authors) (2017) NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74. pp. 38-46. ISSN 0959-8049

Harris, DA, Thorne, K, Hutchings, H et al. (16 more authors) (2016) Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR). BMJ Open, 6 (11). e012496. ISSN 2044-6055

Gollins, S and Sebag-Montefiore, D (2016) Neoadjuvant treatment strategies for locally advanced rectal cancer. Clinical Oncology, 28 (2). 146 - 151. ISSN 0936-6555

Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407

Middleton, G, Brown, S, Lowe, C et al. (17 more authors) (2013) A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). European Journal of Cancer, 49 (16). 3507 - 3516. ISSN 0959-8049

Conference or Workshop Item

West, NP, Kodavatiganti, R, Hemmings, G et al. (6 more authors) (2015) Pre-Treatment and Post-Treatment Epidermal Growth Factor Receptor Pathway Mutations in a Prospective Phase II Trial (NWCOG EXCITE) of Cetuximab-Containing Chemoradiation in Locally Advanced Rectal Cancer. In: Dublin Pathology 2015: 8th Joint Meeting of the British Division of the International Academy of Pathologyand the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin.

Proceedings Paper

West, NP, Kodavatiganti, R, Hundal, ET et al. (2 more authors) (2015) Residual Tumour Cell Density and the Relationship to Survival Following Pre-Operative Chemoradiation in Locally Advanced Rectal Cancer: Results of the NWCOG RICE Trial. In: Journal of Pathology. Dublin Pathology 2015. 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin, Ireland. Wiley , S22-S22.

Gollins, S, Sebag-Montefiore, D, Adams, R et al. (9 more authors) (2015) A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). In: Journal of Clinical Oncology. 2015 ASCO Annual Meeting, 29 May - 02 Jun 2015, Chicago, IL, USA. American Society of Clinical Oncology .